KIMBERLY GREEN: Open Payments
NPI 1902187909 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $50 |
| Novo Nordisk Inc | 1 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Optinose US, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: Ozempic, XIFAXAN, BREZTRI, Xhance, ZEPBOUND, PAXLOVID, MOUNJARO, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
